Prevalence of ABO and RhD blood group phenotypes in the Croatian population and in patients with severe COVID-19 in Croatia.
Journal
Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
26
11
2021
accepted:
21
01
2021
pubmed:
19
3
2022
medline:
15
12
2022
entrez:
18
3
2022
Statut:
ppublish
Résumé
The aim of this study was to determine the distribution of ABO and RhD blood group phenotypes in the general population in the Republic of Croatia and among hospitalized patients with severe COVID-19. Data on ABO and RhD blood groups of all blood donors in Croatia (who donated blood during the period 2015-2020) and patients and pregnant women tested at the Croatian Institute of Transfusion Medicine during the 2-year period, 2019-2020, were obtained from the e-Delphyn blood bank information system. A total of 614,673 results were analyzed in this group. The other group consisted of 780 COVID-19 patients hospitalized with severe COVID-19. Data are presented as total number and percentages and a comparison of proportions test was performed. The most frequent ABO phenotype in the general population is A (38%), followed by O (37%), B (18%) and AB (7%). RhD positive individuals accounted for 81% of the general population and RhD negative for the other 19%. Among COVID-19 patients, phenotype A was the most frequent (42%), followed by phenotypes O (32%), B (17%) and AB (9%). Thus blood group A was significantly more common among COVID-19 patients than among the general population, whereas blood group O was significantly less frequent. This study provides the first official results of the distribution of ABO and RhD blood group phenotypes in the general population in Croatia. Moreover, this study confirms other researchers' observations about the predominance of the A blood group phenotype among COVID-19 patients.
Sections du résumé
BACKGROUND
The aim of this study was to determine the distribution of ABO and RhD blood group phenotypes in the general population in the Republic of Croatia and among hospitalized patients with severe COVID-19.
MATERIALS AND METHODS
Data on ABO and RhD blood groups of all blood donors in Croatia (who donated blood during the period 2015-2020) and patients and pregnant women tested at the Croatian Institute of Transfusion Medicine during the 2-year period, 2019-2020, were obtained from the e-Delphyn blood bank information system. A total of 614,673 results were analyzed in this group. The other group consisted of 780 COVID-19 patients hospitalized with severe COVID-19. Data are presented as total number and percentages and a comparison of proportions test was performed.
RESULTS
The most frequent ABO phenotype in the general population is A (38%), followed by O (37%), B (18%) and AB (7%). RhD positive individuals accounted for 81% of the general population and RhD negative for the other 19%. Among COVID-19 patients, phenotype A was the most frequent (42%), followed by phenotypes O (32%), B (17%) and AB (9%). Thus blood group A was significantly more common among COVID-19 patients than among the general population, whereas blood group O was significantly less frequent.
DISCUSSION
This study provides the first official results of the distribution of ABO and RhD blood group phenotypes in the general population in Croatia. Moreover, this study confirms other researchers' observations about the predominance of the A blood group phenotype among COVID-19 patients.
Identifiants
pubmed: 35302480
pii: 2022.0311-21
doi: 10.2450/2022.0311-21
pmc: PMC9726616
doi:
Substances chimiques
Rh-Hr Blood-Group System
0
ABO Blood-Group System
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
489-494Références
Iran J Pathol. 2020 Summer;15(3):156-160
pubmed: 32754209
Br J Haematol. 2020 Jul;190(1):24-27
pubmed: 32379894
Blood Transfus. 2021 Jul;19(4):317-326
pubmed: 34059188
Transfusion. 2004 May;44(5):703-6
pubmed: 15104651
Indian J Med Res. 2014 Jan;139(1):105-11
pubmed: 24604045
Ann Hematol. 2020 Sep;99(9):2113-2118
pubmed: 32656591
Blood Transfus. 2021 Jan;19(1):54-63
pubmed: 33196417
Br J Haematol. 2020 Aug;190(4):e204-e208
pubmed: 32609874
Turk J Med Sci. 2020 Jun 4;50(4):679-683
pubmed: 32496734
Blood Adv. 2020 Oct 27;4(20):4981-4989
pubmed: 33057633
Clin Infect Dis. 2021 Jul 15;73(2):328-331
pubmed: 32750119
Blood Adv. 2020 Oct 27;4(20):4990-4993
pubmed: 33057631
J Infect Dis. 2002 Feb 1;185(3):393-6
pubmed: 11807723
Blood. 2007 Oct 1;110(7):2250-8
pubmed: 17502454